TGFBR1 (transforming growth factor beta receptor 1)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
7046 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Transforming growth factor beta receptor 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
TGFBR1 |
SynonymsGene synonyms aliases
|
AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, TBR-i, TBRI, TGFR-1, tbetaR-I |
ChromosomeChromosome number
|
9 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
9q22.33 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs11466445 |
GCGGCGGCGGCGGCG>-,GCG,GCGGCG,GCGGCGGCG,GCGGCGGCGGCG,GCGGCGGCGGCGGCGGCG,GCGGCGGCGGCGGCGGCGGCG,GCGGCGGCGGCGGCGGCGGCGGCG,GCGGCGGCGGCGGCGGCGGCGGCGGCG |
Benign, conflicting-interpretations-of-pathogenicity, uncertain-significance, likely-benign, benign-likely-benign |
Intron variant, inframe deletion, inframe insertion, genic upstream transcript variant, coding sequence variant |
rs111426349 |
C>A,G,T |
Pathogenic, uncertain-significance |
Coding sequence variant, synonymous variant, missense variant |
rs111854391 |
C>A,T |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant, stop gained |
rs113605875 |
G>A,C,T |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs121918710 |
T>G |
Pathogenic |
Coding sequence variant, missense variant |
rs121918711 |
A>G |
Pathogenic |
Coding sequence variant, missense variant |
rs121918712 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs121918713 |
G>T |
Pathogenic |
Coding sequence variant, missense variant, intron variant |
rs145033378 |
C>T |
Likely-benign, conflicting-interpretations-of-pathogenicity |
Synonymous variant, 5 prime UTR variant, coding sequence variant |
rs148176750 |
A>G |
Likely-benign, conflicting-interpretations-of-pathogenicity |
Missense variant, intron variant, coding sequence variant |
rs190878719 |
G>A |
Conflicting-interpretations-of-pathogenicity, benign-likely-benign, likely-benign |
Coding sequence variant, synonymous variant, intron variant |
rs387906696 |
A>G |
Uncertain-significance, risk-factor |
Missense variant, 5 prime UTR variant, coding sequence variant |
rs387906697 |
C>T |
Risk-factor, pathogenic |
Stop gained, coding sequence variant |
rs587776865 |
G>C |
Uncertain-significance, risk-factor |
Missense variant, 5 prime UTR variant, coding sequence variant |
rs587776866 |
A>C |
Risk-factor |
Splice acceptor variant |
rs727503470 |
G>A,T |
Uncertain-significance, likely-pathogenic |
Missense variant, coding sequence variant |
rs730880223 |
A>G |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs759805984 |
T>A,C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs760079636 |
G>A |
Likely-pathogenic, pathogenic-likely-pathogenic |
Coding sequence variant, missense variant |
rs767589799 |
G>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs772339721 |
A>G,T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223811 |
G>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223812 |
C>T |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs863223814 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223815 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223816 |
A>C,G |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs863223817 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223819 |
A>G |
Pathogenic |
Coding sequence variant, missense variant |
rs863223822 |
A>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223829 |
AAG>- |
Pathogenic |
Coding sequence variant, inframe deletion |
rs863223832 |
C>A,T |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs869025535 |
G>A |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs878854714 |
C>T |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Synonymous variant, coding sequence variant, genic upstream transcript variant, intron variant |
rs886038919 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs886038954 |
->TG |
Pathogenic |
Coding sequence variant, frameshift variant |
rs886039176 |
T>C,G |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs1057524497 |
G>A,T |
Pathogenic, uncertain-significance, conflicting-interpretations-of-pathogenicity |
Coding sequence variant, stop gained, missense variant |
rs1060502040 |
C>T |
Pathogenic |
Coding sequence variant, intron variant, stop gained |
rs1060502042 |
G>A |
Likely-pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs1131691342 |
C>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1554700603 |
->TGG |
Pathogenic |
Coding sequence variant, inframe insertion |
rs1554700672 |
G>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1554701881 |
A>C,G |
Likely-pathogenic |
Splice acceptor variant |
rs1554701911 |
G>T |
Pathogenic |
Coding sequence variant, missense variant |
rs1554701914 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1554702262 |
G>A |
Pathogenic |
Splice donor variant |
rs1554702463 |
G>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1564161224 |
G>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1588585506 |
G>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1588585570 |
C>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT000687 |
hsa-let-7c-5p |
qRT-PCR, Luciferase reporter assay, Western blot |
19841744 |
MIRT003271 |
hsa-miR-204-5p |
Luciferase reporter assay |
20056717 |
MIRT004650 |
hsa-miR-128-3p |
Luciferase reporter assay, Western blot |
20054641 |
MIRT004650 |
hsa-miR-128-3p |
CLASH |
23622248 |
MIRT004650 |
hsa-miR-128-3p |
PAR-CLIP |
23592263 |
MIRT007379 |
hsa-miR-140-5p |
Luciferase reporter assay |
23401231 |
MIRT021634 |
hsa-miR-142-3p |
Microarray |
17612493 |
MIRT021634 |
hsa-miR-142-3p |
HITS-CLIP |
22473208 |
MIRT021634 |
hsa-miR-142-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
24558198 |
MIRT021634 |
hsa-miR-142-3p |
Western blot |
28146434 |
MIRT027382 |
hsa-miR-101-3p |
Sequencing |
20371350 |
MIRT027382 |
hsa-miR-101-3p |
Immunofluorescence, qRT-PCR |
24817606 |
MIRT027865 |
hsa-miR-98-5p |
Microarray |
19088304 |
MIRT032178 |
hsa-let-7d-5p |
Sequencing |
20371350 |
MIRT053633 |
hsa-let-7f-5p |
Microarray |
22942087 |
MIRT053635 |
hsa-miR-130a-3p |
Microarray |
22942087 |
MIRT053663 |
hsa-miR-181a-5p |
Microarray |
22942087 |
MIRT053663 |
hsa-miR-181a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
22714950 |
MIRT054663 |
hsa-let-7g-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
24291274 |
MIRT054832 |
hsa-let-7b-5p |
GFP reporter assay, Western blot, ELISA |
24978044 |
MIRT106691 |
hsa-miR-1343-3p |
HITS-CLIP |
23313552 |
MIRT106693 |
hsa-miR-6783-3p |
HITS-CLIP |
23313552 |
MIRT173470 |
hsa-miR-202-5p |
Luciferase reporter assay, Western blot |
28373289 |
MIRT173481 |
hsa-miR-1283 |
PAR-CLIP |
22291592 |
MIRT173515 |
hsa-miR-4668-5p |
HITS-CLIP |
23313552 |
MIRT173532 |
hsa-miR-8083 |
PAR-CLIP |
23592263 |
MIRT323787 |
hsa-miR-27a-3p |
PAR-CLIP |
23592263 |
MIRT323788 |
hsa-miR-216a-3p |
PAR-CLIP |
23592263 |
MIRT323789 |
hsa-miR-27b-3p |
PAR-CLIP |
23592263 |
MIRT323789 |
hsa-miR-27b-3p |
Luciferase reporter assay, Western blot |
28095798 |
MIRT323791 |
hsa-miR-3681-3p |
PAR-CLIP |
23592263 |
MIRT372394 |
hsa-miR-3927-3p |
HITS-CLIP |
23313552 |
MIRT372395 |
hsa-miR-6831-5p |
HITS-CLIP |
23313552 |
MIRT437849 |
hsa-miR-376c-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
23424236 |
MIRT438737 |
hsa-miR-135b-5p |
ChIP-seq, Luciferase reporter assay, qRT-PCR, Western blot |
24802670 |
MIRT466408 |
hsa-miR-6826-3p |
PAR-CLIP |
23592263 |
MIRT466409 |
hsa-miR-6795-3p |
PAR-CLIP |
23592263 |
MIRT466410 |
hsa-miR-6887-3p |
PAR-CLIP |
23592263 |
MIRT466411 |
hsa-miR-3156-5p |
PAR-CLIP |
23592263 |
MIRT496743 |
hsa-miR-4480 |
PAR-CLIP |
22291592 |
MIRT496744 |
hsa-miR-8063 |
PAR-CLIP |
22291592 |
MIRT698502 |
hsa-miR-6888-3p |
HITS-CLIP |
23313552 |
MIRT698503 |
hsa-miR-466 |
HITS-CLIP |
23313552 |
MIRT698504 |
hsa-miR-6739-5p |
HITS-CLIP |
23313552 |
MIRT698505 |
hsa-miR-6733-5p |
HITS-CLIP |
23313552 |
MIRT698506 |
hsa-miR-3153 |
HITS-CLIP |
23313552 |
MIRT698507 |
hsa-miR-4646-5p |
HITS-CLIP |
23313552 |
MIRT698508 |
hsa-miR-204-3p |
HITS-CLIP |
23313552 |
MIRT698509 |
hsa-miR-6742-3p |
HITS-CLIP |
23313552 |
MIRT698510 |
hsa-miR-6852-5p |
HITS-CLIP |
23313552 |
MIRT698511 |
hsa-miR-939-3p |
HITS-CLIP |
23313552 |
MIRT698512 |
hsa-miR-4643 |
HITS-CLIP |
23313552 |
MIRT698513 |
hsa-miR-4789-3p |
HITS-CLIP |
23313552 |
MIRT698514 |
hsa-miR-3529-5p |
HITS-CLIP |
23313552 |
MIRT698515 |
hsa-miR-379-5p |
HITS-CLIP |
23313552 |
MIRT732226 |
hsa-miR-490-3p |
Luciferase reporter assay, Western blot |
26714817 |
MIRT734034 |
hsa-miR-20a-5p |
Immunoblot, Immunofluorescence, Luciferase reporter assay, qRT-PCR |
26729221 |
MIRT734924 |
hsa-miR-181c-5p |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
26682928 |
MIRT735136 |
hsa-miR-199a-5p |
Luciferase reporter assay, Microarray, qRT-PCR, Western blot |
25938468 |
|
Transcription factors
|
Transcription factor |
Regulation |
Reference |
SMAD7 |
Repression |
15221015 |
WWP1 |
Repression |
15221015 |
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000186 |
Process |
Activation of MAPKK activity |
IDA |
18625725 |
GO:0001501 |
Process |
Skeletal system development |
ISS |
|
GO:0001701 |
Process |
In utero embryonic development |
ISS |
|
GO:0001822 |
Process |
Kidney development |
ISS |
|
GO:0001824 |
Process |
Blastocyst development |
IEA |
|
GO:0001837 |
Process |
Epithelial to mesenchymal transition |
IDA |
15761148 |
GO:0001937 |
Process |
Negative regulation of endothelial cell proliferation |
IEA |
|
GO:0001938 |
Process |
Positive regulation of endothelial cell proliferation |
ISS |
|
GO:0002088 |
Process |
Lens development in camera-type eye |
IEA |
|
GO:0003222 |
Process |
Ventricular trabecula myocardium morphogenesis |
ISS |
|
GO:0003223 |
Process |
Ventricular compact myocardium morphogenesis |
ISS |
|
GO:0003342 |
Process |
Proepicardium development |
ISS |
|
GO:0004672 |
Function |
Protein kinase activity |
IDA |
19736306 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IBA |
21873635 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IDA |
12065756, 18625725 |
GO:0005024 |
Function |
Transforming growth factor beta-activated receptor activity |
IC |
1326540 |
GO:0005024 |
Function |
Transforming growth factor beta-activated receptor activity |
IDA |
12015308, 14633705 |
GO:0005024 |
Function |
Transforming growth factor beta-activated receptor activity |
IMP |
18625725 |
GO:0005024 |
Function |
Transforming growth factor beta-activated receptor activity |
IMP |
1333888 |
GO:0005025 |
Function |
Transforming growth factor beta receptor activity, type I |
IBA |
21873635 |
GO:0005025 |
Function |
Transforming growth factor beta receptor activity, type I |
IDA |
8752209 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IDA |
11157754 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IPI |
1333888 |
GO:0005515 |
Function |
Protein binding |
IPI |
8622651, 10025408, 11278302, 11279102, 11583628, 12015308, 14517293, 14580334, 15702480, 15761148, 17099224, 18243111, 18625725, 18758450, 18974388, 19732720, 20856203, 22344298, 23723426, 24263861, 24658140, 25893292, 26583432 |
GO:0005524 |
Function |
ATP binding |
IDA |
12065756 |
GO:0005634 |
Component |
Nucleus |
IDA |
26583432 |
GO:0005768 |
Component |
Endosome |
IDA |
26583432 |
GO:0005886 |
Component |
Plasma membrane |
IBA |
21873635 |
GO:0005886 |
Component |
Plasma membrane |
IDA |
17878231, 25893292 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005923 |
Component |
Bicellular tight junction |
IDA |
15761148 |
GO:0006355 |
Process |
Regulation of transcription, DNA-templated |
IDA |
14517293 |
GO:0006355 |
Process |
Regulation of transcription, DNA-templated |
IMP |
15702480 |
GO:0006468 |
Process |
Protein phosphorylation |
IBA |
21873635 |
GO:0006468 |
Process |
Protein phosphorylation |
IDA |
12015308, 12065756 |
GO:0006915 |
Process |
Apoptotic process |
IEA |
|
GO:0007050 |
Process |
Cell cycle arrest |
TAS |
9759503 |
GO:0007165 |
Process |
Signal transduction |
IDA |
14633705 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IBA |
21873635 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IC |
1326540 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IDA |
9389648, 11157754 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IMP |
1333888 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
ISS |
|
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
TAS |
|
GO:0007399 |
Process |
Nervous system development |
IBA |
21873635 |
GO:0007507 |
Process |
Heart development |
IBA |
21873635 |
GO:0007507 |
Process |
Heart development |
ISS |
|
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IMP |
14633705 |
GO:0008354 |
Process |
Germ cell migration |
ISS |
|
GO:0008584 |
Process |
Male gonad development |
IEA |
|
GO:0009791 |
Process |
Post-embryonic development |
IEA |
|
GO:0009952 |
Process |
Anterior/posterior pattern specification |
ISS |
|
GO:0009986 |
Component |
Cell surface |
IDA |
25893292 |
GO:0010628 |
Process |
Positive regulation of gene expression |
IMP |
27162619 |
GO:0010717 |
Process |
Regulation of epithelial to mesenchymal transition |
ISS |
|
GO:0010718 |
Process |
Positive regulation of epithelial to mesenchymal transition |
ISS |
|
GO:0010862 |
Process |
Positive regulation of pathway-restricted SMAD protein phosphorylation |
IDA |
9311995, 9389648 |
GO:0016361 |
Function |
Activin receptor activity, type I |
IBA |
21873635 |
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
IDA |
15761148 |
GO:0018107 |
Process |
Peptidyl-threonine phosphorylation |
IDA |
19736306 |
GO:0019838 |
Function |
Growth factor binding |
IPI |
14517293 |
GO:0030199 |
Process |
Collagen fibril organization |
ISS |
|
GO:0030307 |
Process |
Positive regulation of cell growth |
IDA |
18625725 |
GO:0030335 |
Process |
Positive regulation of cell migration |
IDA |
19736306 |
GO:0030512 |
Process |
Negative regulation of transforming growth factor beta receptor signaling pathway |
TAS |
|
GO:0031396 |
Process |
Regulation of protein ubiquitination |
IDA |
18758450 |
GO:0032331 |
Process |
Negative regulation of chondrocyte differentiation |
ISS |
|
GO:0032924 |
Process |
Activin receptor signaling pathway |
IBA |
21873635 |
GO:0032924 |
Process |
Activin receptor signaling pathway |
ISS |
|
GO:0035556 |
Process |
Intracellular signal transduction |
ISS |
|
GO:0042060 |
Process |
Wound healing |
TAS |
9759503 |
GO:0042118 |
Process |
Endothelial cell activation |
ISS |
|
GO:0043062 |
Process |
Extracellular structure organization |
TAS |
9759503 |
GO:0043235 |
Component |
Receptor complex |
IBA |
21873635 |
GO:0043235 |
Component |
Receptor complex |
IDA |
8774881, 14517293 |
GO:0043393 |
Process |
Regulation of protein binding |
IEA |
|
GO:0043542 |
Process |
Endothelial cell migration |
IEA |
|
GO:0045121 |
Component |
Membrane raft |
IDA |
25893292 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
9311995, 9389648 |
GO:0046332 |
Function |
SMAD binding |
IBA |
21873635 |
GO:0046332 |
Function |
SMAD binding |
IDA |
12065756, 18625725 |
GO:0046332 |
Function |
SMAD binding |
IPI |
8980228, 9311995 |
GO:0046872 |
Function |
Metal ion binding |
IEA |
|
GO:0048179 |
Component |
Activin receptor complex |
IBA |
21873635 |
GO:0048185 |
Function |
Activin binding |
IBA |
21873635 |
GO:0048538 |
Process |
Thymus development |
ISS |
|
GO:0048663 |
Process |
Neuron fate commitment |
ISS |
|
GO:0048701 |
Process |
Embryonic cranial skeleton morphogenesis |
ISS |
|
GO:0048705 |
Process |
Skeletal system morphogenesis |
ISS |
|
GO:0048762 |
Process |
Mesenchymal cell differentiation |
TAS |
9759503 |
GO:0048844 |
Process |
Artery morphogenesis |
ISS |
|
GO:0048870 |
Process |
Cell motility |
IMP |
18625725 |
GO:0050431 |
Function |
Transforming growth factor beta binding |
IDA |
14633705 |
GO:0050431 |
Function |
Transforming growth factor beta binding |
IDA |
11157754 |
GO:0050431 |
Function |
Transforming growth factor beta binding |
IMP |
1333888 |
GO:0050431 |
Function |
Transforming growth factor beta binding |
IPI |
1326540 |
GO:0051272 |
Process |
Positive regulation of cellular component movement |
IMP |
18625725 |
GO:0051491 |
Process |
Positive regulation of filopodium assembly |
IEA |
|
GO:0051496 |
Process |
Positive regulation of stress fiber assembly |
ISS |
|
GO:0051897 |
Process |
Positive regulation of protein kinase B signaling |
IDA |
18625725 |
GO:0060017 |
Process |
Parathyroid gland development |
ISS |
|
GO:0060021 |
Process |
Roof of mouth development |
ISS |
|
GO:0060037 |
Process |
Pharyngeal system development |
ISS |
|
GO:0060043 |
Process |
Regulation of cardiac muscle cell proliferation |
ISS |
|
GO:0060317 |
Process |
Cardiac epithelial to mesenchymal transition |
ISS |
|
GO:0060389 |
Process |
Pathway-restricted SMAD protein phosphorylation |
IDA |
11157754, 12015308, 18625725, 19736306 |
GO:0060391 |
Process |
Positive regulation of SMAD protein signal transduction |
IDA |
9389648 |
GO:0060412 |
Process |
Ventricular septum morphogenesis |
ISS |
|
GO:0060978 |
Process |
Angiogenesis involved in coronary vascular morphogenesis |
ISS |
|
GO:0060982 |
Process |
Coronary artery morphogenesis |
ISS |
|
GO:0070411 |
Function |
I-SMAD binding |
IPI |
11278251 |
GO:0070723 |
Process |
Response to cholesterol |
IDA |
17878231 |
GO:0071363 |
Process |
Cellular response to growth factor stimulus |
IBA |
21873635 |
GO:0071560 |
Process |
Cellular response to transforming growth factor beta stimulus |
IDA |
19494318 |
GO:1905007 |
Process |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
ISS |
|
GO:1905075 |
Process |
Positive regulation of tight junction disassembly |
ISS |
|
GO:1905223 |
Process |
Epicardium morphogenesis |
ISS |
|
GO:2001235 |
Process |
Positive regulation of apoptotic signaling pathway |
IDA |
18758450 |
GO:2001237 |
Process |
Negative regulation of extrinsic apoptotic signaling pathway |
IMP |
18625725 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P36897 |
Protein name |
TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) |
Protein function |
Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. |
PDB |
1B6C
,
1IAS
,
1PY5
,
1RW8
,
1TBI
,
1VJY
,
2L5S
,
2PJY
,
2WOT
,
2WOU
,
2X7O
,
3FAA
,
3GXL
,
3HMM
,
3KCF
,
3KFD
,
3TZM
,
4X0M
,
4X2F
,
4X2G
,
4X2J
,
4X2K
,
4X2N
,
5E8S
,
5E8T
,
5E8U
,
5E8W
,
5E8X
,
5E8Z
,
5E90
,
5FRI
,
5QIK
,
5QIL
,
5QIM
,
5QTZ
,
5QU0
,
5USQ
,
6B8Y
,
6MAC
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF01064 |
Activin_recp |
34 → 110 |
Activin types I and II receptor domain |
Domain |
PF08515 |
TGF_beta_GS |
176 → 203 |
Transforming growth factor beta type I GS-motif |
Family |
PF00069 |
Pkinase |
205 → 492 |
Protein kinase domain |
Domain |
|
Sequence |
|
Sequence length |
503 |
Interactions |
View interactions |
|
|